Landsberg Moshe 4
4 · BIOCANCELL THERAPEUTICS INC. · Filed Jul 6, 2009
Insider Transaction Report
Form 4
BIOCANCELL THERAPEUTICS INC.BICL.TA
Landsberg Moshe
Vice President of Technology
Transactions
- Purchase
Common Stock, par value $0.01
2009-07-06+7,143→ 8,143 total - Award
Employee Options
2008-12-03+211,250→ 260,000 totalExp: 2018-12-03→ Common Stock, par value $0.01 (211,250 underlying)
Footnotes (3)
- [F1]The average purchase price was 2.80 NIS per share.
- [F2]The exercise price is 1.27 NIS per share.
- [F3]16,250 options shall be exercisable at the end of each calendar quarter, until September 30, 2012